Tucatinib is a small-molecule inhibitor of HER2 used as an active pharmaceutical ingredient in the manufacturing of anticancer therapies. It is primarily researched for its role in targeting HER2-positive breast cancer.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Vinblastine sulfate
pharmaceutical raw material
N-(4-(2-Hydroxy-3-(isopropylamino)propoxy)-phenyl)butyramide hydrochloride
pharmaceutical raw material
Nicardipine-d3 Hydrochloride
pharmaceutical raw material
Meclizine-d8 (hydrochloride)
pharmaceutical raw material
1-(1-hydroxy-2-methylpropan-2-yl)-3-[4-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)anilino]quinazolin-6-yl]thiourea
HZCZAJGNAXZBTF-UHFFFAOYSA-N
CC1=C(C=CC(=C1)NC2=NC=NC3=C2C=C(C=C3)NC(=S)NC(C)(C)CO)OC4=CC5=NC=NN5C=C4
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.